Cargando…

Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders

BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell–dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yu, Shi, Ziyan, Zhang, Wei, Zhu, Lin, Tang, Shanshan, Chen, Hongxi, Wang, Xiaofei, Du, Qin, Li, Shuaicheng, Zhang, Ying, Luo, Wenqin, Jin, Xin, Fang, Mingyan, Zhou, Hongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326831/
https://www.ncbi.nlm.nih.gov/pubmed/37414573
http://dx.doi.org/10.1212/NXI.0000000000200134
_version_ 1785069504895647744
author Miao, Yu
Shi, Ziyan
Zhang, Wei
Zhu, Lin
Tang, Shanshan
Chen, Hongxi
Wang, Xiaofei
Du, Qin
Li, Shuaicheng
Zhang, Ying
Luo, Wenqin
Jin, Xin
Fang, Mingyan
Zhou, Hongyu
author_facet Miao, Yu
Shi, Ziyan
Zhang, Wei
Zhu, Lin
Tang, Shanshan
Chen, Hongxi
Wang, Xiaofei
Du, Qin
Li, Shuaicheng
Zhang, Ying
Luo, Wenqin
Jin, Xin
Fang, Mingyan
Zhou, Hongyu
author_sort Miao, Yu
collection PubMed
description BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell–dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immunosuppressive and modulating agents, effective methods to predict the efficacy of these therapeutics are lacking. METHODS: In this study, high-throughput T-cell receptor (TCR) sequencing was performed on peripheral blood from 151 pretreatment patients with AQP4-IgG(+) NMOSD and 151 healthy individuals. We compared the TCR repertoire of those with NMOSD with that of healthy individuals and identified TCR clones that were significantly enriched in NMOSD. In addition, we treated 28 patients with AQP4-IgG(+) NMOSD with immunosuppressants and followed up for 6 months to compare changes in NMOSD-specific TCRs (NMOSD-TCRs) before and after treatment. Moreover, we analyzed transcriptome and single-cell B-cell receptor (BCR) data from public databases and performed T-cell activation experiments using antigenic epitopes of cytomegalovirus (CMV) to further explore the triggers of AQP4-IgG(+) NMOSD. RESULTS: Compared with healthy controls, patients with AQP4-IgG(+) NMOSD had significantly reduced diversity and shorter CDR3 length of TCRβ repertoire. Furthermore, we identified 597 NMOSD-TCRs with a high sequence similarity that have the potential to be used in the diagnosis and prognosis of NMOSD. The characterization of NMOSD-TCRs and pathology-associated clonotype annotation indicated that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection, which was further corroborated by transcriptome and single-cell BCR analysis results from public databases and T-cell activation experiments. DISCUSSION: Our findings suggest that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection. In conclusion, our study provides new clues to uncover the causative factors of AQP4-IgG(+) NMOSD and provides a theoretical foundation for treating and monitoring the disease.
format Online
Article
Text
id pubmed-10326831
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103268312023-07-08 Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders Miao, Yu Shi, Ziyan Zhang, Wei Zhu, Lin Tang, Shanshan Chen, Hongxi Wang, Xiaofei Du, Qin Li, Shuaicheng Zhang, Ying Luo, Wenqin Jin, Xin Fang, Mingyan Zhou, Hongyu Neurol Neuroimmunol Neuroinflamm Research Article BACKGROUND AND OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell–dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immunosuppressive and modulating agents, effective methods to predict the efficacy of these therapeutics are lacking. METHODS: In this study, high-throughput T-cell receptor (TCR) sequencing was performed on peripheral blood from 151 pretreatment patients with AQP4-IgG(+) NMOSD and 151 healthy individuals. We compared the TCR repertoire of those with NMOSD with that of healthy individuals and identified TCR clones that were significantly enriched in NMOSD. In addition, we treated 28 patients with AQP4-IgG(+) NMOSD with immunosuppressants and followed up for 6 months to compare changes in NMOSD-specific TCRs (NMOSD-TCRs) before and after treatment. Moreover, we analyzed transcriptome and single-cell B-cell receptor (BCR) data from public databases and performed T-cell activation experiments using antigenic epitopes of cytomegalovirus (CMV) to further explore the triggers of AQP4-IgG(+) NMOSD. RESULTS: Compared with healthy controls, patients with AQP4-IgG(+) NMOSD had significantly reduced diversity and shorter CDR3 length of TCRβ repertoire. Furthermore, we identified 597 NMOSD-TCRs with a high sequence similarity that have the potential to be used in the diagnosis and prognosis of NMOSD. The characterization of NMOSD-TCRs and pathology-associated clonotype annotation indicated that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection, which was further corroborated by transcriptome and single-cell BCR analysis results from public databases and T-cell activation experiments. DISCUSSION: Our findings suggest that the occurrence of AQP4-IgG(+) NMOSD may be associated with CMV infection. In conclusion, our study provides new clues to uncover the causative factors of AQP4-IgG(+) NMOSD and provides a theoretical foundation for treating and monitoring the disease. Lippincott Williams & Wilkins 2023-07-06 /pmc/articles/PMC10326831/ /pubmed/37414573 http://dx.doi.org/10.1212/NXI.0000000000200134 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Miao, Yu
Shi, Ziyan
Zhang, Wei
Zhu, Lin
Tang, Shanshan
Chen, Hongxi
Wang, Xiaofei
Du, Qin
Li, Shuaicheng
Zhang, Ying
Luo, Wenqin
Jin, Xin
Fang, Mingyan
Zhou, Hongyu
Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
title Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
title_full Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
title_fullStr Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
title_full_unstemmed Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
title_short Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
title_sort immune repertoire profiling reveals its clinical application potential and triggers for neuromyelitis optica spectrum disorders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326831/
https://www.ncbi.nlm.nih.gov/pubmed/37414573
http://dx.doi.org/10.1212/NXI.0000000000200134
work_keys_str_mv AT miaoyu immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT shiziyan immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT zhangwei immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT zhulin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT tangshanshan immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT chenhongxi immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT wangxiaofei immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT duqin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT lishuaicheng immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT zhangying immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT luowenqin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT jinxin immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT fangmingyan immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders
AT zhouhongyu immunerepertoireprofilingrevealsitsclinicalapplicationpotentialandtriggersforneuromyelitisopticaspectrumdisorders